Sunday, January 11, 2015

Roche to Buy Majority Stake in Foundation Medicine, Leader in Tumor Testing



The Swiss pharmaceutical giant Roche will pay more than $1 billion in a deal aimed at improving both cancer treatment and drug development. Read it full By ANDREW POLLACK from NYT Business Day http://ift.tt/1yXTvkR

Source: The New York Times

Latest Posts